wall street’s enthusiasm for all things weightloss related got a fresh boost tuesday after results for a novo nordisk as obesity drug showed a heart benefit weightloss tied stocks jumped following the update with rival eli lilly  co surging as much as 18 the us company extended gains after positive outlook in its earnings report viking therapeutics inc a drug developer working on a treatment similar to novo’s wegovy jumped 12 and ww international inc better known as weight watchers which bought a telemedicine firm that prescribes obesity medications earlier this year soared as much as 24 novo’s wegovy showed a 20 reduction in heart issues compared to those getting a placebo in a closely watched study the results cheered wall street bulls who called it a bestcase scenario and saw the benefit extending the market for wegovy as well as lilly’s mounjaro and possibly removing an obstacle in insurance reimbursement “these medicines were only weight loss drugs but now they are much more than that and we think payers will likely have to provide access to these medicines at this point” mohit bansal a wells fargo analyst wrote in a note morgan stanley analysts project the global obesity market will reach 77 billion in 2030 they had previously estimated 54 billion truist analyst joon lee called the update a “huge win” for the class of drugs wegovy belongs to with “major positive implications to others developing nextgen weight loss drugs” investors rewarding weightloss stocks have helped lilly cement its place as the world’s largest healthcare company and made it one of the top 10 most valuable firms in the world shares hit a record high tuesday adding more than 57 billion to the indianapolisbased company’s market value sales of lilly’s mounjaro a diabetes drug that’s expected to be approved for obesity soon hit nearly 1 billion in the last quarter novo also traded at fresh highs as the danish pharmaceutical company gained ground on the only european megacap that is larger than it read more novo nordisk nears lvmh as europe’s biggest firm by market value makers of syringes for the pharmaceutical industry stevanato group spa and west pharmaceutical services inc also gained rising as much as 10 and 56 respectively